From: Effect of acute and chronic liver diseases on the thyroid function in children
 |  | Group I | Group II | Group III | Group IV | P value |
---|---|---|---|---|---|---|
Acute hepatitis | CLD1 | CLD2 | Control | |||
N=20 | N=20 | N=20 | N=25 | |||
Age | Range Mean ± SD | (2.5-8) 5.5±1.5 | (3-6) 4.6±1 | (3-7) 5±1.3 | (3-7) 5±1 | 0.117 |
Sex | Male Female | 8(40%) 12(60%) | 14(70%) 6(30%) | 10(50%) 10(50%) | 14(56%) 11(44%) | 0.283 |
Heamatemsis | +ve -ve | 2 (10%) 18(90%) | 4(20%) 16(80%) | 7(35%) 13(65%) | Â | 0.1 |
Melena | +ve -ve | 2(10%) 18(90%) | 10(50%) 10(50%) | 15(75%) 5(25%) | Â | 0.001* |
Jaundice | +ve -ve | 20(100%) 0 | 16(80%) 4(20%) | 17(85%) 3(15%) | Â | 0.1 |
Hepatomegaly | +ve -ve | 2(10%) 18(90%) | 12(60%) 8(40%) | 14(70%) 6(30%) | Â | 0.4 |
Splenomegaly | +ve -ve | 2(10%) 18(90%) | 12(60%) 8(40%) | 15(75%) 5(25%) | Â | 0.1 |
Ascitis | +ve -ve | 0 20(100%) | 8(40%) 12(60%) | 10(50%) 10(50%) | Â | 0.001* |
Edema | +ve -ve | 0 20(100%) | 4(20%) 16(80%) | 10(50%) 10(50%) | Â | 0.3 |
Hepatic encephalopathy | +ve -ve | 0 20(100%) | 4(20%) 16(80%) | 2(10%) 18(90%) | Â | 0.1 |